Literature DB >> 33649099

Authors' Reply.

Tadao Akizawa1, Manabu Iwasaki2, Yusuke Yamaguchi3, Yoshikatsu Majikawa4, Michael Reusch5.   

Abstract

Entities:  

Keywords:  chronic kidney disease; erythropoiesis-stimulating agent; hemodialysis; hypoxia-inducible factor; randomized controlled trial

Year:  2021        PMID： 33649099      PMCID： PMC8017550          DOI： 10.1681/ASN.2021010051

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  5 in total

Review 1.  Role of oxygen and the HIF-pathway in polycystic kidney disease.

Authors:  Bjoern Buchholz; Kai-Uwe Eckardt
Journal:  Cell Signal       Date:  2020-01-02       Impact factor: 4.315

2.  HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease.

Authors:  Andre Kraus; Dorien J M Peters; Bernd Klanke; Alexander Weidemann; Carsten Willam; Gunnar Schley; Karl Kunzelmann; Kai-Uwe Eckardt; Bjoern Buchholz
Journal:  Kidney Int       Date:  2018-08-30       Impact factor: 10.612

3.  Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan.

Authors:  Tadao Akizawa; Manabu Iwasaki; Yusuke Yamaguchi; Yoshikatsu Majikawa; Michael Reusch
Journal:  J Am Soc Nephrol       Date:  2020-06-03       Impact factor: 10.121

4.  Roxadustat for Renal Anemia in ESRD from PKD Patients: Is It Safe Enough?

Authors:  Fei Liu; Jingjing Wang; Qing Ye; Haidong Fu; Jianhua Mao
Journal:  J Am Soc Nephrol       Date:  2021-03-01       Impact factor: 10.121

5.  Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS).

Authors:  Evgeny Shutov; Władysław Sułowicz; Ciro Esposito; Avtandil Tataradze; Branislav Andric; Michael Reusch; Udaya Valluri; Nada Dimkovic
Journal:  Nephrol Dial Transplant       Date:  2021-08-27       Impact factor: 5.992
  5 in total
  1 in total

Review 1.  Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease.

Authors:  Patrizia Natale; Suetonia C Palmer; Allison Jaure; Elisabeth M Hodson; Marinella Ruospo; Tess E Cooper; Deirdre Hahn; Valeria M Saglimbene; Jonathan C Craig; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2022-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.